241 related articles for article (PubMed ID: 33257697)
1. TERT promoter alterations could provide a solution for Peto's paradox in rodents.
Vedelek B; Maddali AK; Davenova N; Vedelek V; Boros IM
Sci Rep; 2020 Nov; 10(1):20815. PubMed ID: 33257697
[TBL] [Abstract][Full Text] [Related]
2. TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends.
Yuan X; Dai M; Xu D
Cancer Lett; 2020 Nov; 493():1-9. PubMed ID: 32768523
[TBL] [Abstract][Full Text] [Related]
3. Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Stern JL; Theodorescu D; Vogelstein B; Papadopoulos N; Cech TR
Genes Dev; 2015 Nov; 29(21):2219-24. PubMed ID: 26515115
[TBL] [Abstract][Full Text] [Related]
4. GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
Yuan X; Mu N; Wang N; Strååt K; Sofiadis A; Guo Y; Stenman A; Li K; Cheng G; Zhang L; Kong F; Ekblad L; Wennerberg J; Nilsson IL; Juhlin CC; Larsson C; Xu D
Oncogene; 2019 Feb; 38(7):965-979. PubMed ID: 30181547
[TBL] [Abstract][Full Text] [Related]
5. TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions.
Min J; Shay JW
Cancer Discov; 2016 Nov; 6(11):1212-1214. PubMed ID: 27807101
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.
Mancini A; Xavier-Magalhães A; Woods WS; Nguyen KT; Amen AM; Hayes JL; Fellmann C; Gapinske M; McKinney AM; Hong C; Jones LE; Walsh KM; Bell RJA; Doudna JA; Costa BM; Song JS; Perez-Pinera P; Costello JF
Cancer Cell; 2018 Sep; 34(3):513-528.e8. PubMed ID: 30205050
[TBL] [Abstract][Full Text] [Related]
7. GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
Guo Y; Yuan X; Li K; Dai M; Zhang L; Wu Y; Sun C; Chen Y; Cheng G; Liu C; Strååt K; Kong F; Zhao S; Bjorkhölm M; Xu D
Cell Death Differ; 2020 Jun; 27(6):1862-1877. PubMed ID: 31802036
[TBL] [Abstract][Full Text] [Related]
8. TERT promoter mutations in telomere biology.
Heidenreich B; Kumar R
Mutat Res Rev Mutat Res; 2017; 771():15-31. PubMed ID: 28342451
[TBL] [Abstract][Full Text] [Related]
9. An interaction proteomics survey of transcription factor binding at recurrent TERT promoter mutations.
Makowski MM; Willems E; Fang J; Choi J; Zhang T; Jansen PW; Brown KM; Vermeulen M
Proteomics; 2016 Feb; 16(3):417-26. PubMed ID: 26553150
[TBL] [Abstract][Full Text] [Related]
10. Distinct tumor suppressor mechanisms evolve in rodent species that differ in size and lifespan.
Seluanov A; Hine C; Bozzella M; Hall A; Sasahara TH; Ribeiro AA; Catania KC; Presgraves DC; Gorbunova V
Aging Cell; 2008 Dec; 7(6):813-23. PubMed ID: 18778411
[TBL] [Abstract][Full Text] [Related]
11. Cancer-specific loss of
Amen AM; Fellmann C; Soczek KM; Ren SM; Lew RJ; Knott GJ; Park JE; McKinney AM; Mancini A; Doudna JA; Costello JF
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33758097
[TBL] [Abstract][Full Text] [Related]
12. TERT promoter mutations in familial and sporadic melanoma.
Horn S; Figl A; Rachakonda PS; Fischer C; Sucker A; Gast A; Kadel S; Moll I; Nagore E; Hemminki K; Schadendorf D; Kumar R
Science; 2013 Feb; 339(6122):959-61. PubMed ID: 23348503
[TBL] [Abstract][Full Text] [Related]
13. Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Bell RJ; Rube HT; Kreig A; Mancini A; Fouse SD; Nagarajan RP; Choi S; Hong C; He D; Pekmezci M; Wiencke JK; Wrensch MR; Chang SM; Walsh KM; Myong S; Song JS; Costello JF
Science; 2015 May; 348(6238):1036-9. PubMed ID: 25977370
[TBL] [Abstract][Full Text] [Related]
14. Coevolution of telomerase activity and body mass in mammals: from mice to beavers.
Gorbunova V; Seluanov A
Mech Ageing Dev; 2009; 130(1-2):3-9. PubMed ID: 18387652
[TBL] [Abstract][Full Text] [Related]
15. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
16. Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region.
Li CL; Li CY; Lin YY; Ho MC; Chen DS; Chen PJ; Yeh SH
Hepatology; 2019 Feb; 69(2):498-512. PubMed ID: 30070724
[TBL] [Abstract][Full Text] [Related]
17. Argininosuccinate lyase drives activation of mutant TERT promoter in glioblastomas.
Shi Z; Ge X; Li M; Yin J; Wang X; Zhang J; Chen D; Li X; Wang X; Ji J; You Y; Qian X
Mol Cell; 2022 Oct; 82(20):3919-3931.e7. PubMed ID: 36270249
[TBL] [Abstract][Full Text] [Related]
18. ETS Factor ETV5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid Cancer.
Bullock M; Lim G; Zhu Y; Åberg H; Kurdyukov S; Clifton-Bligh R
Thyroid; 2019 Nov; 29(11):1623-1633. PubMed ID: 31452441
[No Abstract] [Full Text] [Related]
19. hTERT transcription is repressed by Cbfa1 in human mesenchymal stem cell populations.
Isenmann S; Cakouros D; Zannettino A; Shi S; Gronthos S
J Bone Miner Res; 2007 Jun; 22(6):897-906. PubMed ID: 17352650
[TBL] [Abstract][Full Text] [Related]
20. Occurrence, functionality and abundance of the TERT promoter mutations.
Rachakonda S; Hoheisel JD; Kumar R
Int J Cancer; 2021 Dec; 149(11):1852-1862. PubMed ID: 34313327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
